PHARMACEUTICAL INDUSTRY

PAKISTAN VS INDIA
PRESENTED BY: M. Shaheer, M. Saad, M. Tayyab, Syed Ali Hashim
 OVERVIEW
INDIA PAKISTAN
2023-2024 annual revenue was $41000 million domestic US$1,712.00m annual revenue

Exports were $25000 million in 2022-2023 Exports in 2022-23 were $328 Million
Value of industry $50 Billion ( 15 x bigger than Pakistan’s Value of industry is $3.2 billion
industry)
GDP contribution 1.72% GDP contribution is 1%

Exports to 200+ countries like UK, USA and Africa Exports to Central Asia, Far East Asia and Africa. Exported
to 60+ industries

Worldwide ranking is that it is the 14th largest exporter 17th largest exporter
of pharmaceuticals

Employees are 2.7 million (75 lac women) Approximately 240,000 people employed (35% women)
PAKISTAN
PAKISTAN
INDIA
INDIA
 Problems faced by
Pakistan

• Susceptibility to interruptions in the supply

chain caused by reliance on imported
essential materials.
• Absence of domestic research and
development efforts, with a reliance on
foreign technology.
• Inadequate enforcement of intellectual
property rights and patent laws.
• Issues with quality assurance and adherence
to standards, resulting in the presence of
inferior and fake drugs in the market.
• Occurrences of inferior and counterfeit
medications.
Problems faced by India
• Dependence on imported raw
materials and active
pharmaceutical ingredients (APIs).
• Necessity for greater investment in
research and development to
foster innovation.
• Challenges related to patent laws
and issues with compulsory
licensing.
• Difficulties in adhering to Good
Manufacturing Practices (GMP).
• Widespread occurrence of
counterfeit drugs.
STRATEGIC OBJECTIVE

• Enhance sector competitiveness by streamlining regulatory processes and

offering tax incentives to attract more investors to the pharmaceutical
industry.

• Establish partnerships with international pharmaceutical firms to leverage

advanced technologies and practices, thereby boosting production
capabilities and product quality.

• Create a collaborative platform that integrates government, industry, and

academic resources to foster research, development, and commercialization
of innovative pharmaceutical products.
CHOSEN STRATEGY

• Establish partnerships with international pharmaceutical is good

because:
1. Gain cutting-edge technologies and manufacturing practices to
enhance efficiency and quality.
2. Leverage international partners' distribution networks for easier
access to new markets and assistance in navigating foreign
regulatory environments.
3. Attract foreign investment and increase exports, contributing
positively to the local economy.